Search
Follow us:  linkedin twitter slideshare youtube google + pinterest
 
Business Operations > Benchmarking and Quality

Benchmarking and Quality Best Practices

Best Practices, LLC has conducted extensive research in the field of Benchmarking and Quality. Browse through and sample our published Benchmarking and Quality research in the topics below:


      View all Benchmarking and Quality research
 
Effective Thought Leader Management: Leadership, Relationships and TechnologyThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Effective Thought Leader Management: Leadership, Relationships and Technology" STUDY OVERVIEW With so many of its activities affecting new product development and performance, medical affairs is recognized as one of the most important functions within pharma organizations. Thought leader management is one of the critical responsibilities of medical affairs groups because companies look to thought leaders to inform and guide clinical programs. Some of the key components of an effective thought leader management program include its leadership structure and approach to relationship development. Best Practices LLC performed this research study to identify how leading pharma companies structure and organize their thought leader management organizations, to examine the drivers of thought leader management relationships and to highlight new technologies used to maintain relationships. The benchmark data in this study will help companies find better ways to create effective thought leader management strategies that will enhance and inform a critical aspect of an organization’s operations. This document includes mature and emerging markets segment analysis. KEY TOPICS Benchmark Participant Demographics Scope, Structure and Leadership Managing Relationships New Technologies SAMPLE KEY METRICS Number of products involving thought leaders Title of person with oversight responsibility for thought leader management Group with primary oversight for thought leader management Drivers of thought leader management program Importance rating of activities tied to developing thought leader relationships Importance rating of activities tied to maintaining thought leader relationships Value rating of various new technologies used for thought leader interactions in mature markets Value rating of various new technologies used for thought leader interactions in emerging markets SAMPLE KEY FINDING Number of and Interaction Frequency with thought leader s are the Most Important Management Criteria: Within 86% of the mature market companies and all of the emerging market companies number of thought leaders and frequency of interaction with thought leaders drive thought leader management initiatives. MSL Interactions and Clinical Trials Drive TL Relationship Development: In 70% of the mature market segment and 57% of the emerging market segment, MSL interactions is key to thought leader relationship development. In addition, 68% of the mature market and 86% of the emerging market segment reported that Funding Clinical Research is vital for building thought leader relationships. METHODOLOGY Forty survey responses from Medical Affairs leaders at 32 pharmaceutical and medical device companies in the mature market and Emerging Markets. This report captures insights on both Mature and emerging market segments.

Effective Thought Leader Management: Interaction Tactics and ChallengesThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Effective Thought Leader Management: Interaction Tactics and Challenges" STUDY OVERVIEW As the healthcare landscape evolves, the role of Medical Affairs functions within pharma organizations has become increasingly important. Among the many responsibilities of medical affairs groups, thought leader management is considered critical because companies look to thought leaders to inform and guide clinical programs. Best Practices, LLC performed this research study to better understand thought leader interaction frequency and channels. The research also explores challenges and critical strategies to mitigate the negative effects of a changing regulatory landscape. The benchmark data in this study will help companies find better ways to create effective thought leader management strategies that will enhance and inform a critical aspect of an organization’s operations. This document includes mature and emerging markets segment analysis. KEY TOPICS Benchmark Participant Demographics Interaction Frequency & Channel Thought Leader Access Challenges Challenges in Interactions SAMPLE KEY METRICS Frequency of contact with National and Regional thought leaders in mature markets Frequency of contact with National and Regional thought leaders in emerging markets Annual interaction with thought leaders in mature markets Annual interaction with thought leaders in emerging markets Face-to-Face visits per year in mature markets Face-to-Face visits per year in emerging markets Thought leader access challenges in mature markets Thought leader access challenges in emerging markets Level of interactions with health care payers & providers in mature markets Level of interactions with health care payers & providers in mature markets SAMPLE KEY FINDING Frequency of Contact with Regional TLs: Both mature market and emerging market companies contact regional TLs less than they contact national TLs. On average, mature market companies contact regional TLs 26 times per year, and emerging markets companies contact regional TLs 30 times a year. Relationship Challenges: Within mature market segment companies top threats to interactions with thought leaders are increasing regulatory barriers and internal changes among TLs / institutions in how they approach industry. Emerging market segment companies are expecting similar challenges in interactions with thought leaders. However, in addition to the barriers related to thought leaders or their home institutions, shrinking medical affairs budgets will impact emerging markets. METHODOLOGY Forty survey responses from Medical Affairs leaders at 32 pharmaceutical and medical device companies in the mature market and emerging markets. This study includes segment perspectives for both mature and emerging markets.

Medical Affairs Excellence: Showing the Value of the Medical Affairs FunctionThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Medical Affairs Excellence: Showing the Value of the Medical Affairs Function" STUDY OVERVIEW The changing healthcare landscape has pushed the Medical Affairs function into an increasingly important role involving clinical development, regulatory compliance and market education. While the importance of the medical function is recognized, Medical Affairs leaders often find it challenging to identify strong performance metrics to demonstrate the value of their function to key internal stakeholders. Best Practices, LLC undertook this study to help organizations find better ways to create and communicate strong Medical Affairs performance metrics to demonstrate value to leadership. Leading insights and metrics in the document will help Medical Affairs leaders create a blueprint for showing the value of the function to internal leadership. KEY TOPICS Study Overview Key Recommendations Key Findings & Insights Metrics for MA Activities to Show the Success to Stakeholders Communicating the Value of Medical Affairs SAMPLE KEY METRICS Effectiveness of Overall Medical Affairs Metrics in communicating the value and success of the organization to stakeholders Effectiveness of Scientific Publications Metrics, Medical Education Metrics, Thought Leader Management, MSL Metrics and Medical/Clinical Operations Metrics in communicating the value and success of organization to stakeholders Relative importance of Medical Affairs activities to senior leadership Methods/Channels used to communicate the value of Medical Affairs activities to stakeholders SAMPLE KEY FINDINGS Scientific Publication Metrics: 60% of the benchmark class thinks that % publications in top-tier journals is a highly effective metric. In addition, more than 40% of the participants agree that % papers and publications accepted is highly effective to evaluate scientific publication performance. Segments: We observed an important difference in perceived effectiveness of % publications in top-tier journals between MCS and the rest of the benchmark class. While one thirds of MCS doesn’t find this metric effective, rest of the benchmark class thinks that % publications in top-tier journals is highly effective or effective to measure their publication performance. METHODOLOGY Best Practices, LLC engaged 29 executives from 26 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices. 11 participants make up the Large Companies Segment, while the Mid-Size Companies Segment consists of 10 participants and Small Companies Segment consists of 8 participants.

 


 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links

Follow us: 

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information